US2003119906A1PendingUtilityA1

Pharmaceutical forms for the oral administration of mesna

Assignee: ASTA MEDICAL AGPriority: Apr 27, 1998Filed: Jan 3, 2003Published: Jun 26, 2003
Est. expiryApr 27, 2018(expired)· nominal 20-yr term from priority
A61K 9/2095A61K 31/185
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to pharmaceutical forms for oral administration in the form of tablets, film-coated tablets, pellets or granules comprising at least 88% of mesna, produced by granulation with up to 15% of water, based on the amount of solid employed, and also tablets, film-coated tablets, pellets or granules comprising at least 80% of mesna, produced by direct compression or compaction without the use of organic solvents.

Claims

exact text as granted — not AI-modified
1 . Pharmaceutical forms for oral administration in the form of tablets, film-coated tablets, pellets or granules comprising at least 88% of mesna, produced by granulation with up to 15% of water, based on the amount of solid employed.  
     
     
         2 . Pharmaceutical forms for oral administration in the form of tablets, film-coated tablets, pellets or granules comprising at least 80% of mesna, produced by direct compression or compaction.  
     
     
         3 . Process for the production of pharmaceutical forms for oral administration in the form of tablets, film-coated tablets, pellets or granules comprising at least 88% of mesna, according to  claim 1 , by granulation with up to 15% of water, based on the amount of solid employed, without the use of organic solvents.  
     
     
         4 . Process for the production of pharmaceutical forms for oral administration in the form of tablets, film-coated tablets, pellets or granules comprising at least 80% of mesna, according to  claim 2 , by direct compression or compaction without the use of organic solvents.

Join the waitlist — get patent alerts

Track US2003119906A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.